Factors related to CSII compliance

Diabetes and Metabolism

Volumn 31, Issue 1, 2005, Pages 90-95

  Ronsin, O ^a   Jannot Lamotte, M F ^a   Vague, P ^a   Lassman Vague, V ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Continuous subcutaneous insulin infusion; Reasons for discontinuation; Retrospective study; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; NEEDLE; PATIENT COMPLIANCE; PATIENT EDUCATION; PREGNANT WOMAN;

EID: 14744268558     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70173-8     Document Type: Article

References (10)

1. Leblanc H, Selam JL. Le traitement par pompe portable à insuline en France, un an après l'attribution du TIPS (nov.2000). infu-systèmes, 2002, 19, 2-5.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-86.
3. Avant infu-systems international: le point sur les pompes portables dans le monde. Infu-systemes, 2002, 19, 14-5.
4. Lassmann-Vague V, Guerci B, Hanaire-Broutin H, Leblanc H, Renard E, Thervet F, Vague P. Insulin pumps (portable pump for subcutaneous perfusion of insulin. Diabete Metab, 1995, 21, 371-7.
5. Mecklenburg RS, Benson JW, Becker NM, et al. Clinical use of the insulin infusion pump in 100 patients with type I diabetes. N Engl J Med, 1982, 307, 513-8.
6. Pickup JC, Sherwin RS, Tamborlane WV, Rizza RA, Service FJ. Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems. Diabetes, 1985, 34, 37-41.
7. Pickup JC, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. B Med J, 2002, 324, 705.
8. Guinn TS. Bailey GJ, Mecklenburg RS. Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy. Diabetes Care, 1988, 11, 46-51.
9. Bell DS, Ackerson C, Cutter G, Clements R. Factors associated with discontinuation of continuous subcutaneous insulin infusion. Am J Med Sci, 1988, 295, 23-8.
10. Floyd JC, Cornell RG, Jacober SJ, et al. A prospective study identifying risk factors for discontinuance of insulin pump therapy. Diabetes Care, 1993, 16, 1470-8.